Clostridium difficile infection, Current Opinion in Gastroenterology, vol.28, issue.1, pp.1-9, 2012. ,
DOI : 10.1097/MOG.0b013e32834bc9a9
Available from: http://www.ncbi.nlm.nih.gov/books Host and pathogen factors for Clostridium difficile infection and colonization, Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium difficile Infection -NCBI Bookshelf [Internet]. [cited 2012 Feb 9], 2011. ,
Clostridium difficile in children: Colonisation and disease, Journal of Infection, vol.63, issue.2, pp.105-118, 2011. ,
DOI : 10.1016/j.jinf.2011.05.016
Risk Factors and Outcomes Associated With Severe Clostridium difficile Infection in Children. The Pediatric Infectious Disease Journal, Feb, vol.31, issue.2, pp.134-142, 2012. ,
Intestinal flora in new-born infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Archives of Pediatrics & Adolescent Medicine, Feb, vol.149, issue.2, p.390, 1935. ,
Occurrence of Clostridium difficile in infections of man, J. Bacteriol, vol.84, pp.65-72, 1962. ,
THE TOXICITY OF PENICILLIN AS PREPARED FOR CLINICAL USE, The American Journal of the Medical Sciences, vol.206, issue.5, 1943. ,
DOI : 10.1097/00000441-194311000-00011
Gastro-enterostomy for cicatrizing ulcer of the pylorus ,
FATAL ENTERITIS, A.M.A. Archives of Surgery, vol.68, issue.4, pp.486-90, 1954. ,
DOI : 10.1001/archsurg.1954.01260050488011
Staphylococcal enterocolitis--treatment with oral vancomycin. Annals of internal medicine, p.1, 1966. ,
Clindamycin-associated colitis. A prospective study ,
Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in Hamsters, Journal of Infectious Diseases, vol.136, issue.5, pp.701202-701211, 1977. ,
DOI : 10.1093/infdis/136.5.701
The association of viral activation with penicillin toxicity in guinea pigs and hamsters, Yale J Biol Med, vol.47, issue.3, pp.166-81, 1974. ,
Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia, New England Journal of Medicine, vol.298, issue.10, pp.531-535, 1978. ,
DOI : 10.1056/NEJM197803092981003
Infection, Clinical Infectious Diseases, vol.16, issue.s1, pp.4-11, 2008. ,
DOI : 10.1086/521861
Clostridium difficile: isolation and characteristics (Plate VIII), Journal of Medical Microbiology, vol.9, issue.2, pp.129-165, 1976. ,
DOI : 10.1099/00222615-9-2-129
Conclusions., Infection Control & Hospital Epidemiology, vol.17, issue.03, pp.201-207, 2011. ,
DOI : 10.1086/511640
Clostridium difficile spore germination: an update, Research in Microbiology, vol.161, issue.9, pp.730-734, 2010. ,
DOI : 10.1016/j.resmic.2010.09.007
Nosocomial acquisition of Clostridium difficile infection, American Journal of Infection Control, vol.18, issue.1, pp.204-214, 1989. ,
DOI : 10.1016/0196-6553(90)90215-E
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) ?. Infection Control and Hospital Epidemiology, pp.431-55, 2010. ,
Current Status of Clostridium difficile Infection Epidemiology, Clinical Infectious Diseases, vol.32, issue.1, pp.65-70, 2012. ,
DOI : 10.1086/657633
Super toxins from a super bug: structure and function of Clostridium difficile toxins, Biochemical Journal Jun, vol.15436, issue.3, pp.517-543, 2011. ,
??? More Difficult Than Ever, New England Journal of Medicine, vol.359, issue.18, pp.1932-1972, 2008. ,
DOI : 10.1056/NEJMra0707500
Infections à Clostridium difficile. médecine/sciences, Feb, vol.1526, issue.2, pp.153-161, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01491841
<i>Clostridium difficile</i> Toxins: Mediators of Inflammation, Journal of Innate Immunity, vol.103, issue.2, pp.149-58, 2012. ,
DOI : 10.1073/pnas.0604725103
Clostridium difficile Toxin???Induced Inflammation and Intestinal Injury Are Mediated by the Inflammasome, Gastroenterology, vol.139, issue.2, pp.542-552, 2010. ,
DOI : 10.1053/j.gastro.2010.04.005
ABSTRACT, Infection and Immunity, vol.79, issue.4, pp.1498-503, 2011. ,
DOI : 10.1128/IAI.01196-10
Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet, Feb, vol.28351, issue.9103, pp.633-639, 1998. ,
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet, pp.189-93, 2001. ,
A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity, Clinical Infectious Diseases, vol.343, issue.26, pp.302-309, 2007. ,
DOI : 10.1056/NEJM200012283432604
Pseudomembranous Colitis: Spectrum of Imaging Findings with Clinical and Pathologic Correlation, RadioGraphics, vol.19, issue.4, pp.887-97, 1999. ,
DOI : 10.1148/radiographics.19.4.g99jl07887
Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature, Obstetrics and Gynecology International, vol.2010, pp.1-3, 2010. ,
Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea, The American Journal of Gastroenterology, vol.86, issue.3 ,
DOI : 10.1056/NEJM199401273300406
???Associated Diarrhea with High Morbidity and Mortality, New England Journal of Medicine, vol.353, issue.23, pp.2442-2451, 2005. ,
DOI : 10.1056/NEJMoa051639
Clostridium difficile Infection Associated with Antineoplastic Chemotherapy: A Review, Clinical Infectious Diseases, vol.17, issue.1, pp.109-122, 1993. ,
DOI : 10.1093/clinids/17.1.109
Clostridium difficile colitis associated with the use of antineoplastic agents, European Journal of Clinical Microbiology, vol.143, issue.1, pp.10-13, 1984. ,
DOI : 10.1093/infdis/143.1.42
Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil, Clinical and Translational Oncology, vol.99, issue.2, pp.258-61, 2005. ,
DOI : 10.1016/S0039-6109(16)45635-5
Clostridium difficileColitis Associated with Cisplatin-Based Chemotherapy in Ovarian Cancer Patients, Gynecologic Oncology, vol.61, issue.3, pp.369-72, 1996. ,
DOI : 10.1006/gyno.1996.0158
Fatal Clostridium difficile infection associated with vinorelbine chemotherapy: case report and literature review, Journal of Infection and Chemotherapy, vol.16, issue.3, 2010. ,
DOI : 10.1007/s10156-010-0041-0
Recurrent Clostridium difficile diarrhea associated with mitoxantrone and etoposide: a case report and review, Pharmacotherapy, 1997. ,
Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer, Cancer Chemotherapy and Pharmacology, vol.44, issue.0, pp.26-28, 1999. ,
DOI : 10.1007/s002800051113
Clostridium difficile-associated diarrhea in rheumatoid arthritis patients who are receiving therapy with low-dose chlorambucil, Arthritis & Rheumatism, vol.17, issue.11, pp.2090-2091, 1997. ,
DOI : 10.1093/clinids/17.1.109
Fatal Fulminant Clostridium difficile Colitis during CHOP Therapy for Lymphoma: An Autopsy Case, Internal Medicine, vol.46, issue.7, pp.401-405, 2007. ,
DOI : 10.2169/internalmedicine.46.6072
URL : https://www.jstage.jst.go.jp/article/internalmedicine/46/7/46_7_401/_pdf
Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients, Expert Rev Anti Infect Ther, 2010. ,
Infection in Patients with Neutropenia, Clinical Infectious Diseases, vol.4, issue.6, pp.786-91, 2001. ,
DOI : 10.3201/eid0404.980412
Clostridium difficile-associated disease in children with solid tumors. Support Care Cancer, 2009. ,
A prospective study of Clostridium difficile infection and colonization in pediatric oncology patients, Journal, vol.16, issue.12, pp.1131-1135, 1997. ,
Epidemiology and Risk Factors for Clostridium difficile Infection in Children, The Pediatric Infectious Disease Journal, vol.30, issue.7, 2011. ,
DOI : 10.1097/INF.0b013e31820bfb29
Clostridium difficile Infection Among Children With Cancer, The Pediatric Infectious Disease Journal, vol.30, issue.7, pp.610-612, 2011. ,
DOI : 10.1097/INF.0b013e31820970d1
Bacterial Diarrhea in Persons with HIV Infection, United States, 1992-2002, Clinical Infectious Diseases, vol.179, issue.6, pp.1621-1628, 1992. ,
DOI : 10.1086/314749
Risk factors for the development of Clostridium difficileassociated diarrhea during a hospital outbreak, Infect Control Hosp Epidemiol, 1991. ,
Acquisition of Clostridium difficile-Associated Diarrhea in Hospitalized Patients Receiving Tube Feeding, Annals of Internal Medicine, vol.129, issue.12, pp.1012-1021, 1998. ,
DOI : 10.7326/0003-4819-129-12-199812150-00004
Gastric acid suppression does not promote clostridial diarrhoea in the elderly, QJM, vol.93, issue.3, pp.175-81, 2000. ,
DOI : 10.1093/qjmed/93.3.175
Effective Detection of Toxigenic Clostridium difficile by a Two-Step Algorithm Including Tests for Antigen and Cytotoxin, Journal of Clinical Microbiology, vol.44, issue.3, pp.1145-1154, 2006. ,
DOI : 10.1128/JCM.44.3.1145-1149.2006
Infection in Patients Discharged from US Short-stay Hospitals, 1996???20031, Emerging Infectious Diseases, vol.12, issue.3, pp.409-424, 2006. ,
DOI : 10.3201/eid1205.051064
Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals, Infection Control & Hospital Epidemiology, vol.32, issue.04, pp.387-90, 2011. ,
DOI : 10.1086/430311
SEVERE CLOSTRIDIUM DIFFICILE???ASSOCIATED DISEASE IN CHILDREN, The Pediatric Infectious Disease Journal, vol.27, issue.10, pp.944-950, 2008. ,
DOI : 10.1097/INF.0b013e3181723d32
Infections among Hospitalized Children, United States, 1997???2006, Emerging Infectious Diseases, vol.16, issue.4, pp.604-613, 1997. ,
DOI : 10.3201/eid1604.090680
Clostridium difficile infection in the pediatric surgery population, Journal of Pediatric Surgery, vol.47, issue.7, pp.1385-1394, 2012. ,
DOI : 10.1016/j.jpedsurg.2011.12.001
Epidemiologic profile of symptomatic gastroenteritis in pediatric oncology patients receiving chemotherapy. Pediatr Blood Cancer, pp.338-380, 2004. ,
Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit., Archives of Disease in Childhood, vol.72, issue.3, 1995. ,
DOI : 10.1136/adc.72.3.219
Increase in the rate of nosocomial Clostridium difficile-associated diarrhoea during shortages of piperacillin-tazobactam and piperacillin, Journal of Antimicrobial Chemotherapy, vol.53, issue.3, pp.549-50, 2004. ,
DOI : 10.1093/jac/dkh127
Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole, Clinical Infectious Diseases, vol.22, issue.3, pp.1586-90, 2005. ,
DOI : 10.1128/IAI.71.3.1608-1610.2003
: response time for treatment with metronidazole and vancomycin, Journal of Antimicrobial Chemotherapy, vol.36, issue.4, pp.673-682, 1995. ,
DOI : 10.1093/jac/36.4.673
Fidaxomicin versus Vancomycin for Clostridium difficile Infection, New England Journal of Medicine Feb, vol.3364, issue.5, pp.422-453, 2011. ,
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial, The Lancet Infectious Diseases [Internet]. 2012 Feb, pp.1473-309970374 ,
DOI : 10.1016/S1473-3099(11)70374-7
Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study, Clin. Infect. Dis. Feb, vol.1548, issue.4, pp.41-46, 2009. ,
Interruption of Recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and Rifaximin, Clinical Infectious Diseases, vol.46, issue.4, pp.846-854, 2007. ,
DOI : 10.1159/000007297
Comparison of Vancomycin, Teicoplanin, Metronidazole, and Fusidic Acid for the Treatment of Clostridium difficile--Associated Diarrhea, Clinical Infectious Diseases, vol.22, issue.5, pp.813-821, 1996. ,
DOI : 10.1093/clinids/22.5.813
In Vitro Susceptibility of Clostridium difficile Clinical Isolates from a Multi-Institutional Outbreak in Southern Quebec, Canada, Antimicrobial Agents and Chemotherapy, vol.50, issue.10, pp.3473-3478, 2006. ,
DOI : 10.1128/AAC.00479-06
Frequent Emergence of Resistance in Clostridium difficile during Treatment of C. difficile-Associated Diarrhea with Fusidic Acid, Antimicrobial Agents and Chemotherapy, vol.50, issue.9, pp.3028-3060, 2006. ,
DOI : 10.1128/AAC.00019-06
Infection, Clinical Infectious Diseases, vol.48, issue.12, pp.1732-1737, 2009. ,
DOI : 10.1086/599224
New antimicrobial agents for patients with Clostridium difficile infections, Current Infectious Disease Reports, vol.36, issue.Pt2, pp.21-29, 2009. ,
DOI : 10.1093/infdis/141.1.92
Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections, Journal of Antimicrobial Chemotherapy, vol.52, issue.8, pp.954-63, 2009. ,
DOI : 10.1128/AAC.00342-08
In Vitro and In Vivo Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for the Treatment of Clostridium difficile. Antimicrobial agents and chemotherapy [Internet], 2012. ,
Multiple Relapses of Clostridium difficile-Associated Diarrhea in a Cancer Patient Successful Control with Long-Term Cholestyramine Therapy, Journal of Pediatric Hematology/Oncology, vol.14, issue.4, pp.361-365, 1992. ,
DOI : 10.1097/00043426-199211000-00015
Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile-Associated Diarrhea, Clinical Infectious Diseases, vol.366, issue.9491, pp.411-431, 2006. ,
DOI : 10.1016/S0140-6736(05)67420-X
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial, Alimentary Pharmacology and Therapeutics, vol.46, issue.1, pp.583-90, 2005. ,
DOI : 10.1128/JCM.41.11.5340-5343.2003
Probiotics for treatment of Clostridium difficile-associated colitis in adults, Cochrane Database of Systematic Reviews, vol.51, issue.6, p.4611, 2008. ,
DOI : 10.1093/jac/dkg254
A Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination With Standard Antibiotics for Clostridium difficile Disease, JAMA: The Journal of the American Medical Association, vol.271, issue.24, pp.1913-1921, 1994. ,
DOI : 10.1001/jama.1994.03510480037031
Saccharomyces boulardii protease inhibits Clostridium difficile toxin a and b-induced effects in human colonic mucosa, Gastroenterology, vol.114, issue.1, pp.302-309, 1999. ,
DOI : 10.1016/S0016-5085(98)83862-6
Saccharomyces boulardii fungemia caused by treatment with a probioticum Available from, BMJ Case Rep, vol.2012, 2012. ,
A cautionary tale for probiotic use in hematopoietic SCT patients???Lactobacillus acidophilus sepsis in a patient with mantle cell lymphoma undergoing hematopoietic SCT, Bone Marrow Transplantation, vol.3, issue.3, 2012. ,
DOI : 10.1016/j.bbmt.2009.06.019
Fecal Bacteriotherapy for Relapsing Clostridium difficile Infection in a Child: A Proposed Treatment Protocol, PEDIATRICS, vol.126, issue.1, 2010. ,
DOI : 10.1542/peds.2009-3363
Intravenous Immunoglobulin for the Treatment of Clostridium difficile Infection: A Review, Digestive Diseases and Sciences, vol.44, issue.Suppl 2, pp.19-26, 2011. ,
DOI : 10.1016/0016-5085(92)91781-X
Intravenous Immunoglobulin for the Treatment of Severe, Refractory, and Recurrent Clostridium difficile Diarrhea, Diseases of the Colon & Rectum, vol.49, issue.5, pp.640-645, 2006. ,
DOI : 10.1007/s10350-006-0511-8
Toxins, New England Journal of Medicine, vol.362, issue.3, pp.197-205, 2010. ,
DOI : 10.1056/NEJMoa0907635
Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile. Vaccine, pp.3946-54, 2007. ,
Impact of Emergency Colectomy on Survival of Patients With Fulminant Clostridium difficile Colitis During an Epidemic Caused by a Hypervirulent Strain, Annals of Surgery, vol.245, issue.2, pp.267-72, 2007. ,
DOI : 10.1097/01.sla.0000236628.79550.e5
Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland, BMC Infectious Diseases, vol.19, issue.3, p.70, 2008. ,
DOI : 10.1016/j.idc.2005.05.002
Clostridium Difficile in Children with Malignant Disease, Pediatric Hematology and Oncology, vol.151, issue.3, pp.269-72, 1991. ,
DOI : 10.1016/0277-5379(85)90008-2
Clostridium difficile colitis, N. Engl. J. Med. Jun, vol.16330, issue.24, p.1755, 1994. ,
Conclusion., Infection Control & Hospital Epidemiology, vol.71, issue.11, pp.1233-1238, 2007. ,
DOI : 10.7326/0003-4819-135-6-200109180-00012
Clostridium difficile--Associated Disease in a Setting of Endemicity: Identification of Novel Risk Factors, Clinical Infectious Diseases, vol.28, issue.2, pp.1543-1552, 2007. ,
DOI : 10.1086/511793
Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children., Gut, vol.35, issue.11, pp.1608-1620, 1994. ,
DOI : 10.1136/gut.35.11.1608
Toxin A Alters In Vitro???Adherent Neutrophil Morphology and Function, The Journal of Infectious Diseases, vol.185, issue.9, pp.1297-306, 2002. ,
DOI : 10.1086/340236
Differential Binding and Internalization of Clostridium difficile Toxin A by Human Peripheral Blood Monocytes, Neutrophils and Lymphocytes, Scandinavian Journal of Immunology, vol.357, issue.3, pp.264-71, 2011. ,
DOI : 10.1016/S0140-6736(00)03592-3
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection, Journal of Hospital Infection, vol.70, issue.4, pp.298-304, 2008. ,
DOI : 10.1016/j.jhin.2008.08.012
Clostridium Difficile-Associated Diarrhea in 200 Canadian Children, Canadian Journal of Gastroenterology, vol.19, issue.8, pp.497-501, 2005. ,
DOI : 10.1155/2005/326296
Clostridium Difficile-Associated Diarrhea in 200 Canadian Children, Canadian Journal of Gastroenterology, vol.19, issue.8, pp.497-501, 2005. ,
DOI : 10.1155/2005/326296
URL : http://doi.org/10.1155/2005/326296
Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease, The American Journal of Gastroenterology, vol.78, issue.7, pp.1769-75, 2002. ,
DOI : 10.1128/IAI.69.4.2762-2765.2001
Treatments, Annals of Internal Medicine, vol.155, issue.12, pp.839-886, 2011. ,
DOI : 10.7326/0003-4819-155-12-201112200-00007
Classification d'après l'Organisation Mondiale de la Santé (OMS), 1979. ,